Skip to main content

Want a detailed portfolio tracker?

Intensity Therapeutics (INTS) P/E (2023 - 2026)

Intensity Therapeutics (INTS) P/E from Oct 2, 2023 to Jun 3, 2026. The TTM Intensity Therapeutics (INTS) P/E is -0.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Intensity Therapeutics (INTS)

YearP/EChange
2026-0.68-30.96%
2025-0.98-35.44%
2024-1.52-96.99%
2023-50.42N/A

Comparison Intensity Therapeutics (INTS) P/E with competitors

Intensity Therapeutics (INTS) P/E is -0.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.25%
NBYStablecoin Development Corp0.10-115.13%
ENLVEnlivex Therapeutics Ltd0.15-122.24%
FGENFibroGen Inc0.24-135.54%
TRAWTraws Pharma Inc0.47-170.00%
FBIOFortress Biotech Inc0.71-204.53%
CHRSCoherus Biosciences Inc0.98-244.81%
ORMPOramed Pharmaceuticals Inc1.47-318.14%
AGENAgenus Inc2.05-403.27%
VIVSVivoSim Labs Inc2.54-475.42%
CRMDCorMedix Inc3.65-639.75%
ABEOAbeona Therapeutics Inc4.20-722.55%
VXRTVaxart Inc4.26-730.93%
CVACCureVac N.V.4.45-758.18%
SRPTSarepta Therapeutics Inc4.62-784.62%
GLPGGalapagos NV4.86-819.35%
RIGLRigel Pharmaceuticals4.92-828.34%
ZVRAZevra Therapeutics Inc4.97-836.41%
ABUSArbutus Biopharma Corp5.69-942.96%
CGENCompugen Ltd7.38-1193.20%
AUPHAurinia Pharmaceuticals Inc9.25-1469.69%
ACADAcadia Pharmaceuticals Inc9.59-1519.53%
OMEROmeros Corporation9.88-1563.27%
PLXProtalix BioTherapeutics Inc9.91-1567.07%
SPROSpero Therapeutics Inc10.73-1689.30%
ADMAAdma Biologics Inc11.33-1777.53%
SVASinovac Biotech Ltd11.44-1793.13%
TBPHTheravance Biopharma Inc11.78-1843.56%
HRMYHarmony Biosciences Holdings Inc12.18-1903.35%
TGTXTG Therapeutics Inc13.18-2051.25%
INCYIncyte Corp13.38-2081.25%
SABSSAB Biotherapeutics Inc14.06-2181.29%
XOMAXOMA Corp14.95-2312.69%
REGNRegeneron Pharmaceuticals Inc14.98-2317.87%
PBYIPuma Biotechnology Inc15.05-2328.26%
EXELExelixis Inc15.79-2438.47%
NAGENiagen Bioscience Inc16.35-2521.40%
CPRXCatalyst Pharmaceuticals Inc17.34-2667.94%
MDXGMimedx Group Inc17.38-2672.47%
ARGXArgen X SE23.07-3515.82%
HALOHalozyme Therapeutics Inc23.20-3534.92%
XOMAOXOMA Corp25.34-3852.38%
VRTXVertex Pharmaceuticals Inc25.66-3898.42%
XOMAPXOMA Corp25.67-3900.54%
CTMXCytomX Therapeutics Inc25.70-3904.66%
ASNDAscendis Pharma A/S26.35-4001.81%
RPRXRoyalty Pharma plc - Class A27.50-4170.78%
SLNOSoleno Therapeutics Inc29.02-4395.81%
LGNDLigand Pharmaceuticals Inc - Class B30.19-4569.21%
BMRNBiomarin Pharmaceutical Inc37.51-5653.07%
APLSApellis Pharmaceuticals Inc39.02-5877.21%
KRYSKrystal Biotech Inc39.70-5977.36%
GMABGenmab40.20-6052.27%
ONCBeiGene Ltd67.03-10023.56%
TECHBio-Techne Corp68.59-10255.73%
VCELVericel Corp80.63-12037.43%
PHARPharming Group N.V.87.74-13090.23%
ALNYAlnylam Pharmaceuticals Inc124.93-18596.86%
TLXTelix Pharmaceuticals Ltd139.89-20811.29%
CORTCorcept Therapeutics Inc158.39-23550.07%